Michael Hallek

Researcher Next ID · RN-002001

Researcher · Medicine

Cologne, Germany

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Chronic Lymphocytic Leukemia Research

Lymphoma Diagnosis and Treatment

Immunodeficiency and Autoimmune Disorders

Acute Lymphoblastic Leukemia research

Chronic Myeloid Leukemia Treatments

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Blood · 2018 · https://doi.org/10.1182/blood-2017-09-806398
Comprehensive genomic profiles of small cell lung cancer
Nature · 2015 · https://doi.org/10.1038/nature14664
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1315226
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)61381-5
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
Blood · 2008 · https://doi.org/10.1182/blood-2007-06-093906

No projects listed.